DME is No Longer Exempt from Sales Tax in South Carolina

Published in Government Relations on August 02, 2024

DME providers in South Carolina (SC) have been exempt from paying sales tax to the state of SC since 2007, provided that the items received by a patient 1) are paid for by either the funds of Medicare of South Carolina Medicaid, 2) are sold by a provider who holds a South Carolina retail sales license and 3) are provided by a supplier whose principal place of business is located in South Carolina, and 4) meet the definition of DME. The language of that tax exemption can be found in S.C. code 12-36-2120(74).

In a June 26, 2024 ruling, the Supreme Court of South Carolina determined that the provision which exempts DME from being subject to sales tax in SC to be unconstitutional, arguing that the language of the original sales tax exemption was unfair and discriminatory against interstate commerce. Under the existing exemption language, out-of-state providers were required to pay sales tax while in-state providers were not. The Court found that the existing exemption language violated the Commerce Clause, and therefore should be stricken and removed altogether from the current code.

Some important takeaways for providers who offer products and services in South Carolina include:

  1. DME sales after June 26, 2024 are subject to sales tax, and all providers, in state or out of state, will need to collect and/or remit sales tax (6%) to the state on the DME sales transactions in South Carolina which occur after that date.
  2. The SC Supreme Court said they are open to allowing a new sales tax exemption to be passed and implemented in the state, it would just have to be worded differently than the previous language that was just voided. Working alongside SC providers and other industry stakeholders, VGM can certainly assist in drafting new tax exemption language in the hopes of getting it through the legislative process and ultimately passed and implemented. That process will take some time (possibly 1-2 years).
  3. Providers who are based outside of South Carolina, and who have been paying taxes all along, could be eligible for a refund from the state of SC. In their ruling and subsequent informational letter, the SC Supreme Court affirmed a circuit court’s previous decision to issue refunds to out-of-state providers who had paid sales tax into the state on their DME sales. Providers interested in requesting a refund can use Form ST-14 to initiate that process.

The removal of the tax exemption for DME will certainly impact DME providers who do business in South Carolina. We will strive to get a new exemption established going forward. In the meantime, providers can certainly have discussions with their payer sources, including Medicaid, Medicaid MCOs, private payers, etc. regarding what the removal of the exemption means to their business and what needs to happen to offset the impact of this change. If providers can’t afford to absorb the additional costs incurred by this change, they may need to request a fee schedule or process adjustments to offset these additional costs.

VGM will continue to monitor this change and will update you regarding any additional changes or information that comes to light regarding the removal of the sales tax exemption for DME in South Carolina. Additional information regarding this topic can also be found in Informational Letter 24-10.


TAGS

  1. billing & reimbursement
  2. dmepos
  3. regulatory
  4. vgm government

From Our Experts

New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here?